10-K: National Research Corporation Files 10-K Report, Details Financial Performance and Risk Factors

National Research Corporation's 10-K filing for the fiscal year ended December 31, 2023, outlines the company's financial results, operational strategies, and potential risks.

Summary

• National Research Corporation's (NRC Health) revenue decreased to $148.58 million in 2023 from $151.57 million in 2022, with a decline in both U.S. and Canadian revenues.
• Direct expenses decreased slightly to $56.02 million, with a reduction in fixed costs offset by an increase in variable costs.
• Selling, general, and administrative expenses increased to $46.62 million due to higher marketing and personnel costs.
• Operating income decreased to $40.05 million, and the operating margin fell to 27% due to lower revenue and increased expenses.
• The company's recurring contract value decreased to $141.86 million, reflecting a strategic shift towards core digital solutions.
• Cash provided by operating activities increased to $38.11 million, primarily due to changes in working capital.
• The company repurchased 462,140 shares of its common stock for $19.1 million under its 2022 program.
• NRC Health's credit agreement includes a $30 million revolving credit facility, a $23.4 million term loan, and a $75 million delayed draw-down term facility.
• The company's headquarters renovation is expected to cost an additional $11.6 million in 2024 and $1.4 million in 2025.
• The company employed 435 associates as of December 31, 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects like increased operating cash flow and share repurchases, but the overall tone is negative due to decreased revenue, operating income, and recurring contract value. The company also faces significant risks and challenges.

Positives

• Cash provided by operating activities increased by 5% year-over-year.
• The company has access to a $30 million revolving credit facility and a $75 million delayed draw-down term facility.
• The company is actively repurchasing shares, indicating confidence in its future prospects.
• The company is investing in its headquarters renovation, which may improve operational efficiency.
• The company's effective tax rate decreased from 26% to 22%.

Negatives

• Revenue decreased by 2% year-over-year.
• Operating income decreased by 14% year-over-year.
• The company's recurring contract value declined by 3% year-over-year.
• Selling, general, and administrative expenses increased due to higher marketing and personnel costs.
• The company experienced a working capital deficit of $11.8 million as of December 31, 2023.

Risks

• The company depends on contract renewals, and failure to retain key clients could adversely affect revenue.
• The healthcare analytics market is highly competitive, with potential for increased price pressure and market share losses.
• Changes in healthcare regulations, economic downturns, and industry consolidation could negatively impact the company's business.
• Outbreaks, pandemics, and global conflicts could adversely affect operations, sales, and financial condition.
• The company faces risks related to data collection, cybersecurity, and intellectual property protection.
• Failures or deficiencies in information technology systems could negatively impact business operations.
• The company's principal shareholders effectively control the company, which could delay or prevent a change of control.
• The market price of the company's common stock may be volatile.

Future Outlook

The company expects inflationary pressures to continue in 2024 and anticipates increased costs, including salary and benefits. They also expect total other expense to increase due to an expected decrease in interest income and increased interest expense. The company believes that its current solutions, combined with emerging market demand, position it to benefit from multiple growth opportunities.

Management Comments

• Management believes that understanding the story is the key to unlocking the highest-quality and truly personalized care.
• Management is focused on capturing expanded market opportunities through serving clients across increasingly interconnected patient, customer, and employee experience markets.
• Management believes that existing sources of liquidity will be sufficient to meet projected capital and debt maturity needs for the foreseeable future.

Industry Context

The healthcare industry is undergoing a transformation towards value-based payment models and increased engagement of healthcare consumers, creating a greater need for customer-centric healthcare. NRC Health's solutions are aligned to address these trends, providing tools to capture, interpret, and improve patient experience data.

Comparison to Industry Standards

• The document mentions Press Ganey as a primary competitor with significantly higher annual revenue, indicating NRC Health is a smaller player in the market.
• The document notes that there is no publicly traded group of peers, making it difficult to compare and benchmark performance to other similar companies.
• The company competes with market research firms and technology solutions which provide survey-based, general market research or voice of the customer feedback capabilities and firms that provide services or products that complement healthcare performance assessments such as healthcare software or information systems.
• The company's focus on the healthcare industry and its cross-continuum presence are highlighted as competitive strengths.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in certain claims and litigation arising in the normal course of business, but management does not believe the final disposition of these claims will have a material adverse effect on the company's financial position, results of operations, or liquidity.

Related Party Transactions

• A director who served on the board until the end of 2021 was also the CEO of Allina Health, which purchased certain of the company's products and services. Total revenue from Allina Health in 2021 was approximately $1.7 million.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue, operating income, and recurring contract value.
• Employees may be affected by changes in compensation structures and potential workforce reductions.
• Customers may be impacted by changes in the company's service offerings and pricing.
• Creditors may be concerned about the company's working capital deficit and debt levels.

Next Steps

• The company will continue to focus on its core digital solutions.
• The company will continue to pursue strategic acquisitions and investments.
• The company will continue to renovate its headquarters building with expected completion in 2025.
• The company will continue to monitor and manage its cybersecurity risks.

Key Dates

Keywords

healthcare analytics, market research, patient experience, subscription services, financial performance, risk factors, internal controls, cybersecurity, revenue, operating income